scPharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Scpharmaceuticals

11/08/2021 13:12

* scPharmaceuticals Inc  SCPH.OQ  reported a quarterly adjusted
loss of 26 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 30 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* scPharmaceuticals Inc's reported EPS for the quarter was a
loss of 26 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* scPharmaceuticals Inc shares had fallen by 9.3% this
quarter and gained 4.7% so far this year.
* The company reported a quarterly loss of $7.06 million.
* Wall Street's median 12-month price target for
scPharmaceuticals Inc is $13.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 11 at 12:12 p.m.  ​All
figures in US dollars unless otherwise stated